newsfilter
← Latest News
GlobeNewswire·

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

SAN CARLOS, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial